bell
The current prices are delayed by 15 mins, login to check live prices.
Kopran Ltd share price logo

Kopran Ltd

(KOPRAN)

₹217.11.09%

as on 04:01PM, 20 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Kopran Ltd Performance

  • Day's Low

    Day's High

    ₹216.5
    Day's Price Range
    ₹222
  • 52 Week's Low

    52 Week's High

    ₹198
    52-Week Price Range
    ₹369.7
1 Month Return+ 9.99 %
3 Month Return-35.98 %
1 Year Return-9.79 %
Previous Close₹219.49
Open₹222.00
Volume78.05K
Upper Circuit-
Lower Circuit-
Market Cap₹1,039.05Cr

Kopran Ltd Key Statistics

P/E Ratio20.01
PEG Ratio4.53
Market Cap₹1,039.05 Cr
P/B Ratio2.99
EPS10.57
Dividend Yield1.16
SectorPharmaceuticals
ROE8.53

Kopran Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹1,039.05 Cr122.99%0.53₹50 Cr₹614 Cr
NA₹435.76 Cr272.24%0.54₹28 Cr₹601 Cr
NA₹15.41 Cr278.33%0.50NANA
BUY₹23,100.09 Cr3.59%0.52NANA
NA₹706.49 Cr-0.07%0.57₹9 Cr₹179 Cr

Kopran Ltd Mutual Fund Holdings

About Kopran Ltd

Kopran, a pharmaceutical company controlled by Parijat Enterprises and promoted by Somani group, came out with a public issue in Nov.92 to finance its backward integration project and expand its antibiotic facility. Its bulk drug plant is approved by the US FDA and UK regulatory authorities, and in 1995 they were awarded Quality Excellence award by Indian Drug Manufacturers Association. Kopran manufactures penicillin and amoxycillin and has collaborations with Germany, South Korea, US and Adac Laboratories.They launched new products for therapeutic groups like asthma, cardiology, diabetes and lifestyle and obtained approval from European Directorate for Quality of Medicines and UK MHRA. Furthermore, they increased their installed capacity of liquids by 3.00 lakhs of liters and tablets/capsules by 270 croresNos during 2001. They also had tied up with EMerck for comarketing a new antiinflammatory drug in India and subsequently launched Cholestat Atorvastatin. Kopran has a high growth rate in exports and has been ranked amongst the top few fastest growing companies in IndiaORG Marg June 2000.

Share Price: ₹217.10 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹1,039.05Cr as of today
Revenue: ₹151.56Cr as on September 2024 (Q3 24)
Net Profit: ₹7.38Cr as on September 2024 (Q3 24)
Listing date: 01 Dec, 1994
Chairperson Name: Susheel Somani
OrganisationKopran Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Kopran Ltd

  • Kopran Reports Decline in Net Sales for September 2024 - 28 Nov, 2024

    Kopran's consolidated net sales for September 2024 stood at Rs 151.56 crore, reflecting a 0.67% year-on-year decline. The net profit after tax was Rs 7.38 crore, down from Rs 13.77 crore in the previous year.
  • Kopran Reports Decline in Sales and Profit - 21 Nov, 2024

    Kopran's standalone net sales for September 2024 fell 25.46% year-on-year to Rs 73.53 crore. Net profit decreased by 38.07% to Rs 6.60 crore, with EPS dropping to Rs 1.37. The stock has seen negative returns of -14.74% over six months and -23.89% over twelve months.

Insights on Kopran Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 142.06 Cr → 152.56 Cr (in ₹), with an average increase of 6.9% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.68% to 1.32% in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 57.1% return, outperforming this stock by 73.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 161.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.49% of holdings in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 54.70% to 53.97% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, KOPRAN stock has moved down by -33.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 18.62 Cr → 7.38 Cr (in ₹), with an average decrease of 37.0% per quarter

Kopran Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹152.59Cr (-)₹158.92Cr (↑4.15%)₹186.08Cr (↑17.09%)₹139.44Cr (↓25.06%)₹151.56Cr (↑8.69%)
Net Income₹13.77Cr (-)₹15.79Cr (↑14.67%)₹18.62Cr (↑17.92%)₹11.10Cr (↓40.39%)₹7.38Cr (↓33.51%)
Net Profit Margin9.02% (-)9.94% (↑10.20%)10.01% (↑0.70%)7.96% (↓20.48%)4.87% (↓38.82%)
Value in ₹ crore
Details2021202220232024
Total Assets₹326.35Cr (-)₹465.44Cr (↑42.62%)₹507.35Cr (↑9.00%)₹512.52Cr (↑1.02%)
Total Liabilities₹79.50Cr (-)₹86.72Cr (↑9.08%)₹111.76Cr (↑28.87%)₹95.65Cr (↓14.41%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹9.97Cr (-)₹48.77Cr (↑389.17%)-₹37.80Cr (↓177.51%)₹16.87Cr (↓144.63%)₹34.96Cr (↑107.23%)

Index Inclusions

BSE Healthcare

₹44,095.46

-1.13 (-505.02%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹55,149.22

-2.11 (-1188.47%)

Kopran Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
44.49%
0.00
Foreign Institutions
1.32%
94.32
Mutual Funds
0%
50.00
Retail Investors
53.97%
-1.32
Others
0.22%
62.79

Kopran Ltd Key Indicators

Details20202021202220232024
Return On Assets %6.3418.8813.115.379.94
Details20202021202220232024
Book Value Per Share (₹)43.8656.6588.491.11101.9
Details20202021202220232024
Earning Per Share (₹)4.8614.2412.665.6510.57
Details20202021202220232024
Return On Equity %5.019.853.758.078.53

Kopran Ltd Valuation

Kopran Ltd in the last 5 years

  • Overview

  • Trends

Lowest (3.00x)

March 24, 2020

Today (20.01x)

December 19, 2024

Industry (56.23x)

December 19, 2024

Highest (53.33x)

September 5, 2023

LowHigh

Kopran Ltd Earnings and Dividends

  • Kopran Ltd Earnings Results

    Kopran Ltd’s net profit fell -46.41% since last year same period to ₹7.38Cr in the Q2 2024-2025. On a quarterly growth basis, Kopran Ltd has generated -33.51% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Kopran Ltd Dividends May,2024

    In the quarter ending March 2024, Kopran Ltd has declared dividend of ₹3 - translating a dividend yield of 2.76%.

    Read More about Dividends

Kopran Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Kopran Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Kopran Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Kopran Ltd shares.

Kopran Ltd (KOPRAN) share price today is ₹217.1

Kopran Ltd is listed on NSE

Kopran Ltd is listed on BSE

  • Today’s highest price of Kopran Ltd is ₹222.
  • Today’s lowest price of Kopran Ltd is ₹216.5.

PE Ratio of Kopran Ltd is 20.01

PE ratio = Kopran Ltd Market price per share / Kopran Ltd Earnings per share

Today’s traded volume of Kopran Ltd(KOPRAN) is 78.05K.

Today’s market capitalisation of Kopran Ltd(KOPRAN) is ₹1039.05Cr.

Kopran Ltd(KOPRANPrice
52 Week High
₹369.7
52 Week Low
₹198

Kopran Ltd(KOPRAN) share price is ₹217.1. It is down -41.28% from its 52 Week High price of ₹369.7

Kopran Ltd(KOPRAN) share price is ₹217.1. It is up 9.65% from its 52 Week Low price of ₹198

Kopran Ltd(KOPRANReturns
1 Day Returns
-2.39%
1 Month Returns
9.99%
3 Month Returns
-35.98%
1 Year Returns
-9.79%